Published
Prevalence and Correlates of Past-Year Psilocybin Use in the United States
No abstract availability was recorded for this entry.
Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Bibliographic context
Derived topics and classifications
Citation graph
22 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
10.1001/jamapsychiatry.2025.303810.7326/annals-24-0314510.1001/jamahealthforum.2024.165310.1016/j.drugalcdep.2024.11108610.1001/jamapsychiatry.2022.410110.1080/15563650.2023.218266410.1176/appi.ajp.2019.1901003510.1176/appi.ajp.2023017210.1176/appi.ajp.2023090210.1001/jamanetworkopen.2025.3134510.1001/jamahealthforum.2024.363010.1016/j.dadr.2023.100149
Indexed papers citing this DOI
Related papers
Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10Medical Uses and Adverse Effects of Psilocybin.The primary care companion for CNS disorders · 2024-05-28Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.The primary care companion for CNS disorders · 2024-01-16Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.Journal of affective disorders · 2023-02-15LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysisJournal of Affective Disorders · 2026-08-01Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2026-07-09Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-06-01